This article is educational and is not medical advice. Rapamycin and metformin are prescription drugs and should only be discussed with a qualified clinician, especially if you have a medical condition, take medications, or are considering any drug, supplement, fasting plan, or experimental longevity therapy.
Download the free 6 Health Numbers to Track After 45 checklist.
1. The Buzz Around Longevity Drugs
If you follow health news, you have likely heard about rapamycin and metformin. These two medications are currently among the most talked-about drugs in longevity research. Headlines often raise big questions about whether they could affect aging biology.
However, it is crucial to understand that “being studied” does not mean “recommended for healthy adults.” While researchers are exploring how these drugs affect the biology of aging, neither is approved as an anti-aging treatment. For adults over 45, understanding the gap between exciting laboratory research and practical, everyday health is essential before being influenced by longevity headlines.
2. Why These Drugs Get Attention
Researchers are interested in metformin and rapamycin because they interact with cellular pathways that are also studied in aging biology.
Metformin is a widely used, inexpensive medication primarily prescribed for type 2 diabetes. Because it influences how the body handles blood sugar and cellular energy, scientists are studying whether it might have broader effects on age-related outcomes. Rapamycin, on the other hand, affects a specific cellular pathway known as mTOR, which acts as a central regulator of cell growth and metabolism. By influencing this pathway, rapamycin has shown intriguing effects in laboratory studies of aging biology.
Despite the enthusiasm, both remain prescription drugs designed to treat specific medical conditions, not casual wellness tools for the general public.
3. Metformin: What It Is and Why Researchers Study It
Metformin is an established prescription medication that has been used for decades to help manage blood sugar levels in people with type 2 diabetes. Its long clinical track record in diabetes care makes it an appealing candidate for further study.
The scientific community is currently organizing the Targeting Aging with Metformin (TAME) trial. This ambitious project aims to test whether metformin may delay the development or progression of age-related conditions—such as heart disease, cancer, and dementia—in older adults [1]. While observational data from diabetic patients and animal studies are interesting, they do not prove that metformin acts as an anti-aging drug for healthy adults [2]. Metformin is not an approved longevity treatment and should not be used for that purpose without clinician guidance.
4. Rapamycin: What It Is and Why Researchers Study It
Rapamycin, also known generically as sirolimus, is a prescription drug primarily used to suppress the immune system, often to prevent organ rejection in transplant patients. It works by inhibiting the mechanistic target of rapamycin (mTOR) pathway.
The mTOR pathway is deeply involved in nutrient sensing, cell growth, and the recycling of cellular components. In laboratory settings, rapamycin has extended lifespan in some animal models, which is one reason researchers continue to study it [3]. While these animal studies are promising, human longevity benefits are not proven. The effects of rapamycin on healthy human aging remain experimental, and it is not recommended for longevity.
5. The Big Difference Between Research and Personal Use
It is easy to read a study about mice living longer and assume the same applies to humans. However, animal results do not automatically translate to human biology. What works in a controlled laboratory environment may not work safely in the complex system of a human body.
A similar caution applies to senolytics research, where early findings around “zombie cells” are interesting but still not a reason for unsupervised self-experimentation.
Furthermore, prescription drugs can have side effects and may interact with other medications. In clinical trials, dosing, timing, and careful patient selection matter immensely. The experimental protocols shared online by enthusiasts are not medical guidance. Healthy adults should never self-experiment with prescription medications without direct clinician supervision.
6. What the Research Looks Like Today
The current landscape of longevity research is active but still developing. For metformin, the focus is on the upcoming TAME trial and other studies investigating its impact on aging-related diseases [1]. For rapamycin and other mTOR inhibitors, clinical trials are exploring their effects on immune function and aging biology, but significant uncertainty remains [4].
At this time, the evidence is still emerging. There is no scientific consensus or proven claim that either drug extends lifespan in humans.
7. Common Risks and Cautions
Because these are prescription medications, they require careful medical supervision. Both drugs can cause medication interactions that must be managed by a doctor. Rapamycin, given its role as an immunosuppressant, carries concerns regarding infection and immune system suppression. It may also affect blood sugar levels and lipid profiles.
Metformin can cause gastrointestinal distress and has specific kidney and liver considerations that require medical monitoring. Where relevant, both drugs also have pregnancy and fertility considerations. This is why clinician supervision is important when discussing any prescription medication.
For a safer way to understand metabolic patterns, see the guide to continuous glucose monitors after 45.
8. What Adults 45+ Can Do Now
Rather than waiting for a pharmaceutical breakthrough, adults over 45 can focus on better-established basics that support healthy aging. A practical approach is to build a personal longevity protocol based on foundational health habits.
Start by tracking blood pressure, A1C or glucose, lipids, waist circumference, and resting heart rate with clinician guidance where appropriate. Physical activity is equally important; prioritize strength training to maintain muscle mass and regular walking or cardio for heart health.
Nutrition and recovery matter as well. Focus on a protein and fiber-focused diet, and do not underestimate the importance of sleep and recovery for energy, mood, and clear thinking.
9. What to Ask Your Clinician
If you are curious about these topics, bring them up at your next checkup. Here are practical questions to ask your clinician:
- Is there any medical reason I should be taking metformin?
- Is rapamycin appropriate for me, or is it experimental for my situation?
- Could either drug interact with my current medications?
- Are my kidney, liver, glucose, and immune markers relevant to these discussions?
- Which proven lifestyle basics should I focus on first?
- Which health numbers should I track over the next 90 days?
- Are there clinical trials relevant to my situation that I should know about?
10. Common Mistakes
When navigating longevity information, avoid these common pitfalls:
- Assuming that because a drug is “studied for longevity,” it is proven to work.
- Copying a biohacker protocol found online.
- Taking prescription drugs without medical supervision.
- Ignoring potential side effects and dangerous drug interactions.
- Chasing experimental drugs before fixing foundational issues like blood pressure, sleep, strength, and metabolic health.
- Confusing mouse lifespan studies with guaranteed human benefits.
- Using supplements or compounded products as substitutes for proper medical care.
11. Next Step
A good next step is to focus on the health numbers and habits you can track today. Download the free 6 Health Numbers to Track After 45 checklist to get started on a safe, evidence-based path to better aging.
References
[1] American Federation for Aging Research. “TAME – Targeting Aging with Metformin.” https://www.afar.org/tame-trial
[2] Mohammed, I., et al. “A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan.” Frontiers in Endocrinology, 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8374068/
[3] Lee, D. J. W., et al. “Targeting ageing with rapamycin and its derivatives in humans: a systematic review.” The Lancet Healthy Longevity, 2024. https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00258-1/fulltext
[4] ClinicalTrials.gov. “Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity (PEARL).” https://clinicaltrials.gov/study/NCT04488601
For a broader view of researchers and clinicians in the field, see this guide to longevity experts to follow in 2026.